PH
Pharming Group N.V.
PHGUF · OTC
$1.11 +0.00% (+$0.00)
Market Cap $835.2M
P/E Ratio 89.00x
Div. Yield -
ROE 3.47%
Bulios Fair Price
$1.6
44.8% upside
Trenutna cena
$1.11
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PHGUF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
33 /100
Expensive EV/EBITDA 20.17x
P/S 2.28x
P/B 3.09x
Growth
68 /100
Growing Rev. growth 23.68%
FCF growth 34.73%
Book val. growth 10.62%
Profitability
46 /100
Moderate Net margin 2.56%
Op. margin 5.51%
FCF margin 7.04%
Quality
22 /100
Poor ROE 3.47%
ROA 2.01%
Asset turnover 0.78x
Debt
77 /100
Low Current ratio 3.01x
Int. coverage 0.02x
Net debt/EBITDA -1.14x
Stability
33 /100
Unstable Rev. volatility 6.93%
EPS volatility 154.56%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PHGUF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Fabrice Chouraqui
Employees
407
Headquarters
Leiden
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report